Researchers have introduced a new treatment system called ScleroSafe™ for venous diseases, successfully treating its first group of patients in Italy. This system, developed by VVT Med Inc., offers a minimally invasive approach to sclerotherapy, which is used to treat varicose veins. The treatment was performed by Dr. Luca Palombi and his team at Fondazione Villa Salus Hospital in Mestre, marking a significant step in VVT Med’s expansion into European markets.

For those looking to age well, this new treatment could mean a safer and more comfortable option for managing varicose veins, which can affect both health and appearance. The ScleroSafe™ System allows for precise delivery of treatment without the need for thermal energy or anesthesia, potentially leading to less pain and quicker recovery times. This can be especially beneficial for individuals who are concerned about the aesthetic and health impacts of varicose veins.

The evidence for this treatment is still in its early stages, as it has just been introduced in a clinical setting with the first patient treatments. While initial results are promising, more extensive studies are needed to fully understand its effectiveness and long-term benefits. The technology is designed to work for a range of vein sizes and aims to improve the overall experience for both patients and physicians.

If you’re considering options for treating varicose veins, stay informed about new treatments like ScleroSafe™. It’s important to consult with a healthcare professional who can provide personalized advice based on your specific health needs and conditions.

Source: globenewswire.com